Jon P. Stonehouse is CEO & President at BIOCRYST PHARMACEUTICALS INC (BCRX). They have made 22 open-market trades across 2 companies since 2007, most recently 2026-06-11.
CIK 0001385496
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
14 open-market purchases totalling $630K since 2007, against 8 sales. Across 14 scored buys the stock is up 2.4% at ninety days, and 1.5 points ahead of the S&P over the same stretch.
14 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 7% | 7% | 14% |
| Avg Move | -16.9% | +1.9% | +2.4% |
| Alpha | -12.2% | +1.6% | +1.5% |
| Scored | 14 | 14 | 14 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCRX | BUY | 2024-05-13 | 2024-05-15 | $5.55 | $167K | -3.3% | -3.6% | +23.3% |
| BCRX | SELL | 2023-02-01 | 2023-02-02 | $10.38 | $2.1M | -2.3% | -16.4% | -21.6% |
| BCRX | SELL | 2022-12-15 | 2022-12-19 | $10.90 | $154K | +8.8% | -4.2% | -24.1% |
| BCRX | SELL | 2022-12-01 | 2022-12-02 | $12.91 | $4.9M | -12.0% | -9.8% | -30.2% |
| BCRX | SELL | 2022-01-11 | 2022-01-13 | $15.04 | $2.8M | -4.1% | +13.9% | -19.4% |
| BCRX | SELL | 2020-12-15 | 2020-12-17 | $8.32 | $2.2M | -7.6% | +11.6% | +63.1% |
| BCRX | BUY | 2019-11-18 | 2019-11-18 | $1.45 | $73K | +60.1% | +77.5% | +64.3% |
| BCRX | SELL | 2018-12-03 | 2018-12-06 | $9.12 | $1.5M | -14.8% | -2.8% | -10.5% |
| BLCM | BUY | 2018-11-09 | 2018-11-13 | $4.56 | $46K | -3.2% | -17.5% | -25.1% |
| BCRX | SELL | 2015-06-19 | 2015-06-22 | $15.02 | $300K | -26.4% | -2.7% | -2.7% |
| BCRX | SELL | 2012-03-02 | 2012-03-05 | $4.78 | $13K | -26.4% | -2.7% | -2.7% |
| BCRX | BUY | 2011-08-08 | 2011-08-09 | $2.52 | $25K | -26.4% | -2.7% | -2.7% |
| BCRX | BUY | 2011-03-18 | 2011-03-18 | $3.40 | $34K | -26.4% | -2.7% | -2.7% |
| BCRX | BUY | 2009-01-30 | 2009-02-03 | $1.62 | $5K | -26.4% | -2.7% | -2.7% |
| BCRX | BUY | 2008-12-01 | 2008-12-02 | $1.48 | $81K | -26.4% | -2.7% | -2.7% |
| BCRX | BUY | 2008-11-03 | 2008-11-03 | $1.75 | $44K | -26.4% | -2.7% | -2.7% |
| BCRX | BUY | 2008-08-12 | 2008-08-13 | $3.10 | $7K | -26.4% | -2.7% | -2.7% |
| BCRX | BUY | 2008-08-11 | 2008-08-13 | $2.95 | $23K | -26.4% | -2.7% | -2.7% |
| BCRX | BUY | 2008-08-04 | 2008-08-04 | $2.82 | $677 | -26.4% | -2.7% | -2.7% |
| BCRX | BUY | 2008-01-31 | 2008-02-04 | $3.50 | $11K | -26.4% | -2.7% | -2.7% |
| BCRX | BUY | 2007-08-13 | 2007-08-14 | $9.90 | $98K | -26.4% | -2.7% | -2.7% |
| BCRX | BUY | 2007-07-31 | 2007-08-02 | $7.06 | $17K | -26.4% | -2.7% | -2.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.